STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading

Key Takeaways STE posted Q3 adjusted EPS of $2.53, matching estimates, while revenues rose 9.5% yoy to $1.50 billion. STE saw sales growth across Healthcare, AST and Life Sciences, but gross margin fell 72 bps on higher costs. STE maintained fiscal 2026 guidance, expecting 8-9% revenue growth and adjusted EPS of $10.15-$10.30. STERIS plc (STE) reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.53, up 9% from the year-ago quarter’s figure. The figure matched the Zacks Consensus Estima ...